H&F Corporate Investors X, Ltd.
Reporting owner on Forms 3, 4 and 5, CIK 1901930.
- Also a 13F filer: H&F Corporate Investors X, Ltd.
- In the filer group H&F Corporate Investors X, Ltd.
H&F Corporate Investors X, Ltd. reported on 1 issuer in 20 filings, the latest a Form 4 filed 2026-11-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| MDLN · Medline Inc.CIK 2046386 | 10% owner | 1 | 2026-11-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| MDLN · Medline Inc.Class A Common Stock | 2026-11-18 | C converted | +1,579,780 | 12,148,039 | Form 4 | |
| MDLN · Medline Inc.Class B Common Stock | 2026-11-18 | J other | -1,579,780 | 70,324,620 | Form 4 | |
| MDLN · Medline Inc.Common Units, derivative | 2026-11-18 | C converted | -1,579,780 | 70,324,620 | Form 4 | |
| MDLN · Medline Inc.Class A Common Stock | 2026-11-17 | C converted | +10,548,949 | 10,568,259 | Form 4 | |
| MDLN · Medline Inc.Class B Common Stock | 2026-11-17 | J other | -10,548,949 | 71,904,400 | Form 4 | |
| MDLN · Medline Inc.Class A Common Stock, holding | 61,054,619 | Form 4 | ||||
| MDLN · Medline Inc.Class A Common Stock, holding | 6,377,698 | Form 4 | ||||
| MDLN · Medline Inc.Class A Common Stock, holding | 3,422,699 | Form 4 | ||||
| MDLN · Medline Inc.Common Units, derivative | 2026-11-17 | C converted | -10,548,949 | 71,904,400 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-468665 | Medline Inc. | 2026-11-19 | ||
| 13F-HR 0001193125-26-455417 | Quarter ended 2026-09-30 | 2026-11-10 | ||
| 13F-HR 0001193125-26-345867 | Quarter ended 2026-06-30 | 2026-08-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-26-217059 | Quarter ended 2026-03-31 | 2026-05-11 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-26-051633 | Quarter ended 2025-12-31 | 2026-02-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-25-276837 | Quarter ended 2025-09-30 | 2025-11-12 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-25-007590 | Quarter ended 2025-06-30 | 2025-08-12 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-25-004981 | Quarter ended 2025-03-31 | 2025-05-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-25-001809 | Quarter ended 2024-12-31 | 2025-02-12 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-24-011166 | Quarter ended 2024-09-30 | 2024-11-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-24-008669 | Quarter ended 2024-06-30 | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-24-004595 | Quarter ended 2024-03-31 | 2024-05-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-24-001946 | Quarter ended 2023-12-31 | 2024-02-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-23-009971 | Quarter ended 2023-09-30 | 2023-11-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-23-007425 | Quarter ended 2023-06-30 | 2023-08-11 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-23-003767 | Quarter ended 2023-03-31 | 2023-05-04 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-23-000464 | Quarter ended 2022-12-31 | 2023-01-30 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-22-011887 | Quarter ended 2022-09-30 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-22-008073 | Quarter ended 2022-06-30 | 2022-08-09 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-22-006243 | Quarter ended 2022-03-31 | 2022-05-16 | acceptance time not in the bulk data set |